Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.45 |
| ▸ | DAO | P14920 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.31 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5970609 | 0.86 | GABRA1 (0.52) | GABRA1GABRB2DAOPDK2MGLL | |
| SCHEMBL217965 | 0.83 | BID (0.37) | GABRA1GABRB2CYP3A4 | |
| SCHEMBL1644574 | 0.81 | BID (0.43) | KCNH2 | |
| SCHEMBL3302964 | 0.80 | BID (0.45) | KCNH2 | |
| SCHEMBL535892 | 0.79 | GABRA1 (0.45) | GABRA1GABRB2FFAR1MGLL | |
| SCHEMBL1535598 | 0.78 | GABRA1 (0.45) | GABRA1GABRB2DAOFFAR1CYP3A4 | |
| SCHEMBL9849127 | 0.78 | GABRA1 (0.45) | GABRA1GABRB2DAOFFAR1PDK2 | |
| SCHEMBL1965147 | 0.78 | CYP3A4 (0.33) | CYP3A4 | |
| SCHEMBL2924588 | 0.78 | FFAR1 (0.38) | GABRA1GABRB2FFAR1 | |
| SCHEMBL4952691 | 0.78 | GABRA1 (0.44) | GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7093664-B2 | One-time use composite tool formed of fibers and a biodegradable resin | HALLIBURTON ENERGY SERVICES, INC. (US) | 2006-08-22 | — | — | US | claimed |
| US-20050205265-A1 | One-time use composite tool formed of fibers and a biodegradable resin | HALLIBURTON EENRGY SERVICES, INC. | 2005-09-22 | — | — | US | claimed |
| US-4057672-A | Compounded polyvinyl chloride | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1977-11-08 | — | — | US | claimed |
| WO-2024106426-A1 | CELLULOSE RESIN COMPOSITION AND MOLDED BODY USING SAME | 日本電気株式会社 | 2024-05-23 | — | — | WO | disclosed |
| WO-2024106436-A1 | CELLULOSE RESIN COMPOSITION AND MOLDED BODY USING SAME | 日本電気株式会社 | 2024-05-23 | — | — | WO | disclosed |
| CN-115161879-A | Method for preparing polyvinyl butyral micro-nano fiber through rotor centrifugal spinning and application | 广东职业技术学院 | 2022-10-11 | — | — | CN | disclosed |
| CN-113861315-B | Polyvinyl butyral with sound insulation performance and preparation method thereof | 忠信（清远）光伏材料科技有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-113909738-A | Preparation method and application of ceramic soldering tin head surface treatment coating | 佛山市摩陶新材料科技有限公司 | 2022-01-11 | — | — | CN | disclosed |
| CN-109453411-B | Chitosan dressing | 广州润虹医药科技股份有限公司 | 2021-11-26 | — | — | CN | disclosed |
| CN-210904261-U | Self-adhesive hemostatic artificial dura mater repair tablet | 孟国路 | 2020-07-03 | — | — | CN | disclosed |
| CN-108778768-B | Lithographic printing plate precursor, laminate thereof, and method for producing lithographic printing plate precursor | 富士胶片株式会社 | 2020-04-03 | — | — | CN | disclosed |
| EP-0467164-A2 | Flupirtine in combination with antiparkinsonica against muscle bracing | ASTA Medica Aktiengesellschaft (DE) | 1992-01-22 | — | — | EP | disclosed |
| US-5068233-A | For treatment of asthma, antiallergens or antihistamines | ASTA PHARMA AKTIENGESELLSCHAFT (DE) | 1991-11-26 | — | — | US | disclosed |
| EP-0277352-B1 | SYNERGISTIC MIXTURE OF AZELASTINE AND THEOPHYLLINE OR OF AZELASTINE AND BETA-MIMETICS | ASTA Pharma Aktiengesellschaft (DE) | 1991-10-16 | — | — | EP | disclosed |
| EP-0419998-A2 | Use of alkylphosphonic acid derivatives for the treatment of psoriasis | ASTA Medica Aktiengesellschaft (DE) | 1991-04-03 | — | — | EP | disclosed |
| EP-0378086-A2 | Use of the agent azelastine in the treatment of psoriasis | ASTA Medica Aktiengesellschaft (DE) | 1990-07-18 | — | — | EP | disclosed |
| US-4938748-A | Urinary drainage container comprising external source of biocide | ALZA CORPORATION, A CORP. OF DE | 1990-07-03 | — | — | US | disclosed |
| EP-0357318-A2 | Urinary drainage container comprising external source of biocide | ALZA CORPORATION (US) | 1990-03-07 | — | — | EP | disclosed |
| EP-0324947-A1 | Synergistic combination of decarboxylase inhibitors and L-dopa pellets | ASTA Medica Aktiengesellschaft (DE) | 1989-07-26 | — | — | EP | disclosed |
| EP-0277352-A1 | Synergistic mixture of azelastine and theophylline or of azelastine and beta-mimetics | ASTA Pharma Aktiengesellschaft (DE) | 1988-08-10 | — | — | EP | disclosed |